Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Nov;108(11):1039-44.
doi: 10.1007/s00347-011-2352-7.

[Gingival hyperplasia and visual reduction]

[Article in German]
Affiliations
Case Reports

[Gingival hyperplasia and visual reduction]

[Article in German]
M Haustein et al. Ophthalmologe. 2011 Nov.

Abstract

This case report describes the unilateral acute reduction of vision in the right eye of a 48-year-old woman. The patient was otherwise healthy but 2 days previously had suffered from dizziness and blurred vision. Secondary to this, the patient had already been under dental treatment for 1 week due to gingival swelling. At the first examination a macular branch retinal vein occlusion and Roth spots were found in the right eye by indirect ophthalmoscopy. The immediate diagnostic procedure identified aute amyeloid leukemia (AML) as the cause of the vascular pathology. The AML can be manifested in different ways and the retina is involved in approximately 50% of cases. Due to a secondary hyperviscosity syndrome, which is found in approx. 20% of acute leukaemias, symptomatic central vein occlusion or macular branch vein occlusion can occur. Ophthalmic symptoms can be the first and only signs to be detected. Therefore, ophthalmologists should also consider a systemic disease and initiate a clarification. A differential blood count is indispensable. The results usually improve by a rapidly arranged and suitable therapy. Ophthalmological follow-up examinations are imperative as an initiated chemotherapy can also produce ophthalmological side-effects.

PubMed Disclaimer

References

    1. Ophthalmologe. 1994 Feb;91(1):131-45 - PubMed
    1. Zhonghua Yan Ke Za Zhi. 1996 Nov;32(6):441-4 - PubMed
    1. Ophthalmologe. 2003 Jul;100(7):561-77; quiz 578 - PubMed
    1. Dtsch Med Wochenschr. 2009 Sep;134(39):1935-41 - PubMed
    1. Arch Ophthalmol. 1989 May;107(5):697-700 - PubMed

MeSH terms

LinkOut - more resources